Related Experiment Videos
Cross-reactivity with drugs at the T cell level
Jan P H Depta1, Werner J Pichler
1Division of Allergology, Clinic of Rheumatology and Clinical Immunology / Allergology, Inselspital, University of Bern, Bern, Switzerland.
Current Opinion in Allergy and Clinical Immunology
|July 17, 2003
Summary
Drug hypersensitivity involves T cell cross-reactivity, where the entire drug structure is recognized. Differentiating T cell and antibody responses is crucial for accurate drug allergy labeling and treatment.
Area of Science:
- Immunology
- Pharmacology
- Clinical Medicine
Background:
- Drug hypersensitivity is a significant clinical issue, leading to broad drug class avoidance.
- Mislabeling patients as 'drug-allergic' restricts therapeutic options.
Purpose of the Study:
- To review drug cross-reactivity at the T cell level.
- To understand the mechanisms of T cell-mediated drug recognition.
Main Methods:
- Analysis of T cell clones recognizing various drug classes.
- Examination of T cell recognition patterns for beta-lactam antibiotics, sulfonamides, and local anesthetics.
Main Results:
- T cell clones recognize the entire drug structure, with emphasis on the core and side chains.
- Cross-reactivity at the T cell level involves recognition of broader structural elements.
Conclusions:
- T cell-mediated cross-reactivity differs from antibody-mediated responses.
- Antibodies exclusively recognize drug side chains, unlike T cells.
- Distinguishing between T cell and antibody mechanisms is vital for managing drug hypersensitivity.